Adma Biologics Stock Math Transform Price Ceiling Movement
| ADMA Stock | USD 15.80 0.41 2.66% |
| Symbol |
Transformation |
The output start index for this execution was zero with a total number of output elements of sixty-one. ADMA Biologics Price Ceiling Movement function is a real number to the largest previous price integer.
ADMA Biologics Technical Analysis Modules
Most technical analysis of ADMA Biologics help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for ADMA from various momentum indicators to cycle indicators. When you analyze ADMA charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
How Much Is ADMA Biologics Worth?
ADMA Biologics is a large-cap equity in Biotechnology, Pharmaceuticals, Biotechnology & Life Sciences, Health Care categories. Revenue consistency stabilizes valuation context. We evaluate ADMA Biologics through the lens of long-term portfolio construction and diversification efficiency.
Methodology
Unless otherwise specified, financial data for ADMA Biologics is derived from periodic company reporting (annual and quarterly where available). Asset-level metrics are computed daily by Macroaxis LLC and refreshed regularly based on asset type. ADMA (USA Stocks:ADMA) prices are typically delayed by approximately 20 minutes from primary exchanges for listed equities. Data may be delayed depending on reporting sources and market conventions Valuation estimates and intrinsic-value models use inputs from public financial disclosures and may not represent market consensus.
Assumptions
Macroaxis analytics incorporate public filings and market reference sources and official disclosures from U.S. Securities and Exchange Commission (SEC) via EDGAR and the U.S. Patent & Trademark Office (USPTO). Data harmonization may result in minor timing offsets. All analytics are generated using standardized, rules-based models designed to promote consistency and comparability across instruments. Model assumptions, reference parameters, and selected computational inputs are available in the Model Inputs section. If you have questions about our data sources or methodology, please contact Macroaxis Support.Analyst Sources
ADMA Biologics is covered by 3 analysts. 1 analyst has submitted revenue and/or earnings estimates that may be incorporated into Macroaxis consensus inputs where available. Representative analyst firms may include Morgan Stanley, RBC Capital Markets, Wells Fargo Securities, BMO Capital Markets, Stifel, among others. Updates may occur throughout the day.
Be your own money manager
Tracking ADMA Biologics inside a portfolio is useful because individual winners can still weaken diversification or distort overall risk targets. A disciplined tracking process turns performance data into better decisions instead of more noise.
Generate Optimal Portfolios
Align your risk and return expectations
More Resources for ADMA Stock Analysis
A comprehensive view of ADMA Biologics starts with financial statements and ratio context. Ratio context helps frame profitability, efficiency, and growth trends for Adma Biologics Stock. Selected reports below provide context for ADMA Stock:Trending Equities provides context for diversified portfolio construction. Refined allocation visibility enhances overall portfolio context. This reflects a position in ADMA Biologics within the allocation view. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state. Before investing in ADMA Stock, review our How to Buy ADMA Biologics guide for key considerations.Analysis related to ADMA Biologics should be read together with other portfolio and risk tools before capital is reallocated. That is especially important when the goal is to improve the overall mix of instruments already held. You can also try the CEOs Directory module to screen CEOs from public companies around the world.
Quarterly Earnings Growth -0.53 | Earnings Share 0.6 | Revenue Per Share | Quarterly Revenue Growth 0.184 | Return On Assets |
ADMA Biologics market price can diverge from book value, the accounting figure shown on ADMA balance sheet. Intrinsic value is an estimate of underlying worth, separate from trading price and book value. Market prices can move with sentiment and macro cycles, creating divergence from fundamentals. The valuation process compares these measures for perspective.
It is useful to distinguish ADMA Biologics' value from its trading price, which are computed with different methods. Reviewing financial results, valuation ratios, and competitive positioning helps frame the value discussion. The quoted price is simply the exchange level where supply meets demand.